Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD

References

• Coronavirus Worldometer. [cited 2020 Dec 23]. Available from: www.worldometers.info/coronavirus/Date
   Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. China medical treatment expert group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28;382(18):1708–1720.
   Web of Science ®Google Scholar
• Global strategy for the diagnosis. Management and prevention of chronic obstructive pulmonary disease, Global initiative for chronic obstructive lung disease (GOLD). 2020. Available from: http://www.goldcopd.org/. Cited 2020 Oct 20.
   Google Scholar
• Özdemir T, Demirci NY, Kiliç H, et al. An epidemiologic study of physician-diagnosed chronic obstructive pulmonary disease in the Turkish population: COPDTURKEY-1. Turk J Med Sci. 2020 Feb 13;50(1):132–140.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. http://dx.doi.org/10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Guan W, Liang W, Zhao Y, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547.
   PubMed Web of Science ®Google Scholar
• Signes-Costa J, Núñez-Gil IJ, Soriano JB, et al. HOPE COVID-19 investigators. Prevalence and 30-Day mortality in hospitalized patients with Covid-19 and prior lung diseases. Arch Bronconeumol. 2020 Dec 16:S0300–2896(20)30535–4. Epub ahead of print. PMID: 33423874; PMCID: PMC7744014. DOI:10.1016/j.arbres.2020.11.012
   Web of Science ®Google Scholar
• Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020. DOI:10.1001/jama.2020.4683
   PubMed Web of Science ®Google Scholar
• Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. Epub 2020/02/23PubMed PMID:32077115
   PubMed Web of Science ®Google Scholar
• Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS ONE. 2020;15(5):e0233147. Epub 2020/05/12PubMed PMID:32392262
   PubMed Web of Science ®Google Scholar
• Edis EÇ. Chronic pulmonary diseases and COVID-19. Turk Thorac J. 2020;21(5):345–349.
   PubMed Web of Science ®Google Scholar
• Simpson S, Kay FU, Abbara S, et al. Radiological society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the society of thoracic radiology, the American College of Radiology, and RSNA - secondary publication. J Thorac Imaging. 2020 Jul;35(4):219–227.
   PubMed Web of Science ®Google Scholar
• COVID-19 Guideline: management of Severe Pneumonia, ARDS, Sepsis and Septic Shock [online]. Ministry of Health, Turkey. [cited 2020 Nov 2]. Available from: https://covid19bilgi.saglik.gov.tr/tr/
   Google Scholar
• Jain NK, Thakkar MS, Jain N, et al. Chronic obstructive pulmonary disease: does gender really matter? Lung India. 2011;28(4):258–262.
   PubMedGoogle Scholar
• He Y, Xie M, Zhao J, et al. Clinical characteristics and outcomes of patients with severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD). Med Sci Monit. 2020 Sep;4(26):e927212. PMID: 32883943; PMCID: PMC7491229.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020;26(6):767–772.
   PubMed Web of Science ®Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118.
   PubMed Web of Science ®Google Scholar
• Attaway A, Hatipoğlu U. Management of patients with COPD during the COVID-19 pandemic. Cleve Clin J Med. 2020 Jul 17. DOI:10.3949/ccjm.87a.ccc007. Epub ahead of print. PMID: 32393594.
   PubMed Web of Science ®Google Scholar
• Xiao WW, Xu J, Shi L, et al. Is chronic obstructive pulmonary disease an independent predictor for adverse outcomes in coronavirus disease 2019 patients? Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11421–11427. PMID: 33215464.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of Covid-19: a systemic review and meta-analysis. J Med Virol. 2020 Apr 15; https://doi:10.1002/jmv.2588 92(10): 1915–1921
   Web of Science ®Google Scholar
• Wu F, Zhou Y, Wang Z, et al. Medical treatment expert group for COPD and COVID-19. Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study. J Thorac Dis. 2020 May;12(5):1811–1823. PMID: 32642086; PMCID: PMC7330323.
   PubMed Web of Science ®Google Scholar
• Simons SO, Hurst JR, Miravitlles M, et al. Caring for patients with COPD and COVID-19: a viewpoint to spark discussion. Thorax. 2020 Dec;7512:1035–1039. PMID: 32878969; PMCID: PMC7474898 Epub 2020 Sep 2.
   PubMed Web of Science ®Google Scholar
• Lim JP, Low KYH, Lin NJJ, et al. Predictors for development of critical illness amongst older adults with COVID-19: beyond age to age-associated factors. Arch Gerontol Geriatr. 2021 Dec;24(94):104331. Epub ahead of print. PMID: 33476755; PMCID: PMC7834606.
   PubMedGoogle Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Turan O, Mirici A. Chronic obstructive pulmonary disease and COVID-19. Eurasian J Pulmonol. 2020;22(Suppl 4):56–60.
   Web of Science ®Google Scholar
• Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154–164.
   PubMed Web of Science ®Google Scholar
• Graziani D, Soriano JB, Del Rio-Bermudez C, et al. Characteristics and Prognosis of COVID-19 in Patients with COPD. J Clin Med. 2020 Oct 12;9(10):3259.
   Web of Science ®Google Scholar
• Mellado-Artigas R, Ferreyro BL, Angriman F, et al. High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure. Crit Care. 2021;25(1):58. DOI: 10.1186/s13054-021-03469-w
   PubMed Web of Science ®Google Scholar
• Leung JM, Niikura M, Yang CWT, et al. COVID-19 and COPD. Eur Respir J. 2020 Aug 13;56(2):2002108. PMID: 32817205; PMCID: PMC7424116.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Melendi SE, Pérez MM, Salas CE, et al. COVID-19 with and without pneumonia: clinical outcomes in the internal medicine ward. Medicina (B Aires). Aires B. 2020; 80(Suppl 6): 56–64. English. PMID: 33481734
   PubMedGoogle Scholar